These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 27733957

  • 1. Factors Associated With Musculoskeletal Injuries in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Guy JA, Knight LM, Wang Y, Jerrell JM.
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27733957
    [Abstract] [Full Text] [Related]

  • 2. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM, McIntyre RS, Park YM.
    J Clin Psychiatry; 2014 Nov; 75(11):e1278-83. PubMed ID: 25470092
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for incident major depressive disorder in children and adolescents with attention-deficit/hyperactivity disorder.
    Jerrell JM, McIntyre RS, Park YM.
    Eur Child Adolesc Psychiatry; 2015 Jan; 24(1):65-73. PubMed ID: 24705730
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epidemiology of Treatment for Preschoolers on Kentucky Medicaid Diagnosed with Attention-Deficit/Hyperactivity Disorder.
    Davis DW, Feygin Y, Creel L, Kong M, Jawad K, Sun J, Blum NJ, Lohr WD, Williams PG, Le J, Jones VF, Pasquenza N.
    J Child Adolesc Psychopharmacol; 2020 Sep; 30(7):448-455. PubMed ID: 32614247
    [Abstract] [Full Text] [Related]

  • 8. Risk of Injury According to Attention Deficit Hyperactivity Disorder, Comorbid Mental Illness, and Medication Therapy.
    Merrill RM, Thygerson SM, Palmer CA.
    Pharmacopsychiatry; 2016 Mar; 49(2):45-50. PubMed ID: 26829453
    [Abstract] [Full Text] [Related]

  • 9. Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.
    Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.
    J Manag Care Pharm; 2007 Sep; 13(7):561-9. PubMed ID: 17874862
    [Abstract] [Full Text] [Related]

  • 10. Attention-Deficit/Hyperactivity Disorder Medication and Unintentional Injuries in Children and Adolescents.
    Ghirardi L, Larsson H, Chang Z, Chen Q, Quinn PD, Hur K, Gibbons RD, D'Onofrio BM.
    J Am Acad Child Adolesc Psychiatry; 2020 Aug; 59(8):944-951. PubMed ID: 31302218
    [Abstract] [Full Text] [Related]

  • 11. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.
    Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
    [Abstract] [Full Text] [Related]

  • 12. The association between attention deficit hyperactivity disorder severity and risk of mild traumatic brain injury in children with attention deficit hyperactivity disorder in the United States of America: A cross-sectional study of data from the National Survey of Children with Special Health Care Needs.
    Karic S, DesRosiers M, Mizrahi B, Zevallos J, Rodriguez P, Barengo NC.
    Child Care Health Dev; 2019 Sep; 45(5):688-693. PubMed ID: 31049988
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
    Molife C, Bernauer MJ, Farr AM, Haynes VS, Kelsey D.
    Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
    [Abstract] [Full Text] [Related]

  • 14. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder.
    Perwien A, Hall J, Swensen A, Swindle R.
    J Manag Care Pharm; 2004 Sep; 10(2):122-9. PubMed ID: 15032561
    [Abstract] [Full Text] [Related]

  • 15. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.
    J Manag Care Pharm; 2012 Sep; 18(9):676-89. PubMed ID: 23206211
    [Abstract] [Full Text] [Related]

  • 16. Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
    Liu YC, Chen VC, Yang YH, Chen YL, Gossop M.
    Epidemiol Psychiatr Sci; 2021 Feb 15; 30():e14. PubMed ID: 33583471
    [Abstract] [Full Text] [Related]

  • 17. Patient and provider characteristics related with prescribing of ADHD medication: Nationwide health insurance claims database study in Korea.
    Song I, Lee MS, Lee EK, Shin JY.
    Asia Pac Psychiatry; 2018 Mar 15; 10(1):. PubMed ID: 28631372
    [Abstract] [Full Text] [Related]

  • 18. Factors Differentiating Childhood-Onset and Adolescent-Onset Schizophrenia:A Claims Database Study.
    Jerrell JM, McIntyre RS.
    Prim Care Companion CNS Disord; 2016 Mar 15; 18(2):. PubMed ID: 27486543
    [Abstract] [Full Text] [Related]

  • 19. Association between medication prescription for atopic diseases and attention-deficit/hyperactivity disorder.
    van der Schans J, Pleiter JC, de Vries TW, Schuiling-Veninga CC, Bos JH, Hoekstra PJ, Hak E.
    Ann Allergy Asthma Immunol; 2016 Aug 15; 117(2):186-91. PubMed ID: 27315741
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS, Genel M, Bezman RJ, Slanetz PJ.
    JAMA; 1998 Apr 08; 279(14):1100-7. PubMed ID: 9546570
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.